johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

Business Insider · 17h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

Zacks.com on MSN · 16h

Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.

Chicago Bears hire offensive guru Ben Johnson

Milwaukee Journal-Sentinel on M… · 3h

New Chicago Bears head coach Ben Johnson says he enjoyed beating Packers' Matt LaFleur twice a year as Lions offensive coordinator

New Chicago head coach Ben Johnson didn't waste any time jumping into the Packers-Bears rivarly with his comments directed at Matt LaFleur.

USA TODAY Sports on MSN · 9h

Chicago Bears' Ben Johnson becomes one of youngest head coaches in NFL. See where he ranks

The Bears introduce Ben Johnson as new head coach, continuing a trend started with Sean McVay. Johnson isn't the youngest in the NFL, but he's close.

CBS Chicago on MSN · 2h

Ben Johnson "cannot wait to get to work" coaching "absolutely loaded" Bears team

"Our mission, starting this spring, is to win and to win now," Johnson said at his introductory news conference.

FDA approves Johnson & Johnson’s nasal spray for depression

Fortune on MSN · 3h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

U.S. News & World Report · 11h

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,

Popular Science · 12h

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

The Bears landed Ben Johnson, who didn't want to be anywhere else

The Bears had targeted Johnson as their top candidate since firing head coach Matt Eberflus the day after Thanksgiving, ...

15h

Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond

Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...

MassDevice16h

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

12hon MSN

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of ...

13h

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

2don MSN

What Analysts Think of Johnson & Johnson Stock Ahead of Earnings

Johnson & Johnson is set to report earnings before the bell Wednesday, with analysts expecting revenue and profit growth from ...

Johnson & Johnson Q4 Preview: Can Earnings Bring Health Care 'Back To Life'?

Johnson & Johnson is one of several Dow Jones Industrial Average stocks reporting financial results this week. A look at the ...

TipRanks on MSN3d

Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards

Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Johnson & Johnson Q4 Profit Decreases

Chicago Bears hire offensive guru Ben Johnson

FDA approves Johnson & Johnson’s nasal spray for depression

Related topics